OS Therapies enters $75M ATM equity offering with Jefferies LLC

OS Therapies Inc

On Aug 21, 2026, OS Therapies (OSTX) entered an Open Market Sale Agreement with Jefferies LLC.
Company may sell up to $75 million of common stock via at-the-market offering under Form S-3.
Jefferies earns 3.0% commission on gross proceeds; up to $100,000 in legal fee reimbursements.
Net proceeds to fund clinical trials, R&D programs, and potential complementary acquisitions.
Offering terminates when all shares sold or upon 10 days' notice from either party.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.